Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol.
about
Design of a gelatin microparticle-containing self-microemulsifying formulation for enhanced oral bioavailability of dutasteride.An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer.The biological effects of the hypolipidaemic drug probucol microcapsules fed daily for 4 weeks, to an insulin-resistant mouse model: potential hypoglycaemic and anti-inflammatory effects.
P2860
Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Microencapsulation as a novel ...... l antidiabetic drug, Probucol.
@en
Microencapsulation as a novel ...... l antidiabetic drug, Probucol.
@nl
type
label
Microencapsulation as a novel ...... l antidiabetic drug, Probucol.
@en
Microencapsulation as a novel ...... l antidiabetic drug, Probucol.
@nl
prefLabel
Microencapsulation as a novel ...... l antidiabetic drug, Probucol.
@en
Microencapsulation as a novel ...... l antidiabetic drug, Probucol.
@nl
P2093
P2860
P50
P356
P1476
Microencapsulation as a novel ...... al antidiabetic drug, Probucol
@en
P2093
Frank Arfuso
Hesham S Al-Sallami
Nigel Chen-Tan
Rebecca Negrulj
T K Mukkur
Vance Matthews
P2860
P304
P356
10.2147/DDDT.S67349
P407
P50
P577
2014-09-09T00:00:00Z